Goumidi Louisa, Cottel Dominique, Dallongeville Jean, Amouyel Philippe, Meirhaeghe Aline
INSERM, U744; Institut Pasteur de Lille; Université Lille Nord de France, 1 rue du Pr, Calmette, BP 245, Lille Cedex F-59019, France.
BMC Genet. 2014 May 23;15:62. doi: 10.1186/1471-2156-15-62.
Genome-wide association studies have identified variants associated with obesity-related traits, such as the body mass index (BMI). We sought to determine how the combination of 31 validated, BMI-associated loci contributes to obesity- and diabetes-related traits in a French population sample. The MONA LISA Lille study (1578 participants, aged 35-74) constitutes a representative sample of the population living in Lille (northern France). Genetic variants were considered both individually and combined into a genetic predisposition score (GPS).
Individually, 25 of 31 SNPs showed directionally consistent effects on BMI. Four loci (FTO, FANCL, MTIF3 and NUDT3) reached nominal significance (p ≤ 0.05) for their association with anthropometric traits. When considering the combined effect of the 31 SNPs, each additional risk allele of the GPS was significantly associated with an increment in the mean [95% CI] BMI of 0.13 [0.07-0.20] kg/m2 (p = 6.3x10-5) and a 3% increase in the risk of obesity (p = 0.047). The GPS explained 1% of the variance in the BMI. Furthermore, the GPS was associated with higher fasting glycaemia (p = 0.04), insulinaemia (p = 0.008), HbA1c levels (p = 0.01) and HOMA-IR scores (p = 0.0003) and a greater risk of type 2 diabetes (OR [95% CI] = 1.06 [1.00-1.11], p = 0.03). However, these associations were no longer statistically significant after adjustment for BMI.
Our results show that the GPS was associated with a higher BMI and an insulin-resistant state (mediated by BMI) in a population in northern France.
全基因组关联研究已经确定了与肥胖相关性状(如体重指数(BMI))相关的变异。我们试图确定31个经过验证的与BMI相关的基因座的组合如何影响法国人群样本中与肥胖和糖尿病相关的性状。蒙娜丽莎里尔研究(1578名参与者,年龄在35 - 74岁之间)构成了居住在里尔(法国北部)人群的代表性样本。基因变异既被单独考虑,也被组合成一个遗传易感性评分(GPS)。
单独来看,31个单核苷酸多态性(SNP)中有25个对BMI显示出方向一致的影响。四个基因座(FTO、FANCL、MTIF3和NUDT3)与人体测量学性状的关联达到名义显著性(p≤0.05)。当考虑31个SNP的联合效应时,GPS的每增加一个风险等位基因与平均[95%置信区间]BMI增加0.13[0.07 - 0.20]kg/m²显著相关(p = 6.3×10⁻⁵),肥胖风险增加3%(p = 0.047)。GPS解释了BMI中1%的变异。此外,GPS与更高的空腹血糖(p = 0.04)、胰岛素血症(p = 0.008)、糖化血红蛋白水平(p = 0.01)和胰岛素抵抗指数(HOMA-IR)评分(p = 0.0003)以及2型糖尿病的更高风险相关(比值比[95%置信区间]=1.06[1.00 - 1.11],p = 0.03)。然而,在对BMI进行调整后,这些关联不再具有统计学显著性。
我们的结果表明,在法国北部人群中,GPS与更高的BMI和胰岛素抵抗状态(由BMI介导)相关。